Merck 3Q Revenues: $16.7 billion (+4%) 3Q Earnings: $3.15 billion (-33%) YTD Revenues: $48.5 billion (+7%) YTD Earnings: $13.4 billion (earnings were $1.6 billion YTD23) Comments: KEYTRUDA sales were up 17% to $7.4 billion in the quarter. Newly launched WINREVAIR to treat Pulmonary Arterial Hypertension had sales of $149 million. Gardasil sales were down 10% to $2.3 billion primarily due to lower demand in China, partially offset by higher sales in the U.S. Januvia sales were down 38% to $4...